U.S. COVID-19 cases rise amid vaccine milestone
Dec. 08, 2021 3:14 PM ETJNJ, PFE, MRNA, BNTXBy: Dulan Lokuwithana, SA News Editor127 Comments
- Less than two years into the pandemic, COVID-19 case numbers are on the rise again in the U.S., even as the country has crossed a major milestone in its immunization drive against the disease.
- According to the latest data from the Centers for Disease Control and Prevention (CDC), over 200 million Americans are currently fully vaccinated against COVID-19, a little over 60% of the total population.
- Out of the fully vaccinated, about 56% have opted for two-dose Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) vaccine while ~36% and 8% have received Moderna (NASDAQ:MRNA) and Johnson (NYSE:JNJ) vaccines, respectively.
- Meanwhile, the average number of daily new coronavirus cases in the country has increased to approximately 119,000 this week from nearly 95,000 on Nov. 22, ABC News reports. COVID-related hospitalizations have risen 25% from a month earlier, and the average number of deaths, standing at nearly 1,600 a day, has approached the level seen in October.
- While the Delta variant of the coronavirus has driven the latest surge, the newly emerged Omicron variant has now been found in about 20 states. Today, Pfizer (PFE)/ BioNTech (BNTX) cited early lab data to indicate that three doses of its vaccine protect against the variant.